Map Syntax

Qualcom had all the desirable MAP SYNTAX metrics for a SUPER STOCK run in 1999. It had two forward stock splits alone - Feb 1st 1999 payable May 10th & Nov 2nd 1999 payable Dec 30th. Identifying & riding the wave from (pre-splits) $100 to $1000 was really quite simple if you followed the Map Syntax RULES OF ENGAGEMENT. We model heavily from QCOM to TRAIN THE EYE when mentoring MAP SYNTAX.

Microstrategy is the model PRICE SPIKE. It was SHOCK & AWE even to the most bullish speculators in the 1999 tech bubble. Map Syntax RULES OF ENGAGEMENT would have kept you involved to the long side for a majority of the ride. Live in the moment, read & react and dont have any expectaions about stock. That is the attitude that will serve a speculator best and prevent him form selling to early and ‘Leaving Gobs of $ On the Table’.

JDSU & GLW were beneficiaries of the insatiable demand for bandwidth during the boom of the internet. These two stocks provided the fiber optical wire and components to deliver bandwidth. The cap ex budgets for telecom carriers to build infrastructure was huge and these two companies were beneficiaries of that spending. It was an amazing time for stock speculators in these two stocks.

JDSU & GLW were beneficiaries of the insatiable demand for bandwidth during the boom of the internet. These two stocks provided the fiber optical wire and components to deliver bandwidth. The cap ex budgets for telecom carriers to build infrastructure was huge and these two companies were beneficiaries of that spending. It was an amazing time for stock speculators in these two stocks.

HGSI & AFFX were two monster stocks that capitalized on the coding of the human genome. No profits to speak off, just promises and a bet on the future drove these stocks to deliver 1000% gains in under a 12 month time frame. As a general rule, I avoid biotech & medical stocks all together simply because there is too much headline risk in these names (medical "equipment" stocks I am less concerned about).

HGSI & AFFX were two monster stocks that capitalized on the coding of the human genome. No profits to speak off, just promises and a bet on the future drove these stocks to deliver 1000% gains in under a 12 month time frame. As a general rule, I avoid biotech & medical stocks all together simply because there is too much headline risk in these names (medical "equipment" stocks I am less concerned about).

DRYS & EXM didnt have a sexy new product - “Dry Bulk Shipping”, but they did have massive pricing power. Shipping prices were rising dramatically as the ‘Chin-Dia’ global growth story was all the rage. I distinctly remember the CEO of DRYS stating in an interview, late 2007 when the stock was trading at $120, how there was no end in site and DRYS was going to be an earnings growth story for years. As we can see, that wasnt the case and like most ‘Super Stocks’ it crashed and burned.

DRYS & EXM didnt have a sexy new product - “Dry Bulk Shipping”, but they did have massive pricing power. Shipping prices were rising dramatically as the ‘Chin-Dia’ global growth story was all the rage. I distinctly remember the CEO of DRYS stating in an interview, late 2007 when the stock was trading at $120, how there was no end in site and DRYS was going to be an earnings growth story for years. As we can see, that wasnt the case and like most ‘Super Stocks’ it crashed and burned.

ANR & PCX went on monster runs in early 2008 at a time when the general market was quite poor. Our proprietry ‘Market Risk Model’ signals were negative but ANR, PCX and other coal stocks were screaming ‘price expansion’. Over the long run, we believe it will serve traders best if they place more emphasis on the pattern of the instrument your going to trade vs. the pattern of the general market. Dont over think things; See Signal, Trade Signal, Manage Risk.

PCX & ANR went on monster runs in early 2008 at a time when the general market was quite poor. Our proprietry ‘Market Risk Model’ signals were negative but PCX, ANR and other coal stocks were screaming ‘price expansion’. Over the long run, we believe it will serve traders best if they place more emphasis on the pattern of the instrument your going to trade vs. the pattern of the general market. Dont over think things; See Signal, Trade Signal, Manage Risk.